These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21003729)

  • 1. Sulfadiazine resistant strains of beta hemolytic streptococci; appearance during the course of sulfadiazine prophylaxis at a large naval training center.
    YOUNG DC; BREESE RB
    J Am Med Assoc; 1945 Dec; 129():921-7. PubMed ID: 21003729
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfadiazine prophylaxis; a comparison of the effect on beta hemolytic streptococcic infections and on virus infections.
    WARREN HA
    Proc Am Fed Clin Res; 1945; 2():9. PubMed ID: 20275572
    [No Abstract]   [Full Text] [Related]  

  • 3. An in vitro method for determining the resistance of beta hemolytic streptococci to sulfadiazine.
    TROWBRIDGE M
    J Lab Clin Med; 1946 Feb; 31():248-52. PubMed ID: 21012847
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulfonamide sensitivity determinations of hemolytic streptococci isolated from patients before and after treatment with sulfadiazine.
    HARTMAN TL
    Bull Johns Hopkins Hosp; 1946 Nov; 79(5):342-8. PubMed ID: 20280878
    [No Abstract]   [Full Text] [Related]  

  • 5. The epidemiology of acute respiratory infections conditioned by sulfonamides; effects of sulfadiazine on groups A and G hemolytic streptococci.
    SIEGEL M
    Am J Hyg; 1946 Sep; 44(2):257-67. PubMed ID: 21003022
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary report of an outbreak of streptococcal disease caused by a sulfadiazine resistant group A, type 17 hemolytic streptococcus.
    DELAMATER ED; JENNINGS R; WALLACE AW
    J Infect Dis; 1946; 78():118-27. PubMed ID: 21025254
    [No Abstract]   [Full Text] [Related]  

  • 7. An epidemic caused by a sulfadiazine resistant strain of the streptococcus hemolyticus (group A, type 17).
    ROBERG NB
    J Infect Dis; 1946; 78():135-46. PubMed ID: 21025256
    [No Abstract]   [Full Text] [Related]  

  • 8. Susceptibility to sulfadiazine of hemolytic streptococci recovered in Army camps.
    HAMBURGER M; MATTMAN LH
    Am J Med; 1946 Jul; 1():23-7. PubMed ID: 20989807
    [No Abstract]   [Full Text] [Related]  

  • 9. Outbreak of hemolytic streptococcus throat infection controlled by sulfadiazine.
    LINDBERG RB; COYLE FR
    J Lab Clin Med; 1946 May; 31():544-9. PubMed ID: 21027932
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of penicillin and sulfadiazine as prophylactic agents against streptococcal and non-specific respiratory infections among recruits at a naval training center.
    GEZON HM; COOK JS; MAGOFFIN RL; MILLER CH
    Am J Hyg; 1953 Jan; 57(1):71-100. PubMed ID: 13007686
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemolytic streptococcal sore throat; antibody response following treatment with penicillin, sulfadiazine, and salicylates.
    RANTZ LA; BOISVERT PJ; SPINK WW
    Science; 1946 Mar; 103(2673):352. PubMed ID: 21017951
    [No Abstract]   [Full Text] [Related]  

  • 12. An epidemic caused by a sulfadiazine-resistant strain of Group A Type 17 streptococcus.
    VAN RAVENSWAAY AC; WESTWATER JA; HOLBROOK WP
    Med Clin North Am; 1946 May; ():707-15. PubMed ID: 20983802
    [No Abstract]   [Full Text] [Related]  

  • 13. SULFADIAZINE RESISTANT STREPTOCOCCAL INFECTIONS IN A CIVILIAN COMMUNITY.
    Johnson RD; Hartman TL
    J Clin Invest; 1947 Mar; 26(2):325-8. PubMed ID: 16695421
    [No Abstract]   [Full Text] [Related]  

  • 14. An outbreak of sulfadiazine resistant streptococcus infection at Lowry Field, Colorado.
    WILSON OG
    J Infect Dis; 1946; 78():147-52. PubMed ID: 21025257
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ; Toleman MA; Walsh TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Jun; 55(2):119-27. PubMed ID: 16530373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-hemolytic streptococcic septicemia, acute bacterial endocarditis, acute mastoiditis and embolic brain abscess successfully treated with sulfadiazine and penicillin; report of case.
    CHESTNUT JL
    J Tn State Med Assoc; 1946 Apr; 39():126-31. PubMed ID: 21022642
    [No Abstract]   [Full Text] [Related]  

  • 17. CHEMOPROPHYLAXIS against infections with the hemolytic streptococcus.
    N Engl J Med; 1953 Jul; 249(1):40-2. PubMed ID: 13063681
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical efficacy of prophylactic administration of trimethoprim/sulfadiazine in a Streptococcus equi subsp. zooepidemicus infection model in ponies.
    Ensink JM; Bosch G; van Duijkeren E
    J Vet Pharmacol Ther; 2005 Feb; 28(1):45-9. PubMed ID: 15720514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing trends in β-hemolytic streptococcal bacteremia in Manitoba, Canada: 2007-2012.
    Schwartz IS; Keynan Y; Gilmour MW; Dufault B; Lagacé-Wiens P
    Int J Infect Dis; 2014 Nov; 28():211-3. PubMed ID: 25403914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of proteinase by hemolytic streptococci in various clinical conditions.
    ROTHBARD S; TODD EW
    J Exp Med; 1948 Apr; 87(4):283-94. PubMed ID: 18904214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.